ClinicalTrials.govpublic full text
Neoadjuvant Gemcitabine and Cisplatin in Combination With Perioperative Pembrolizumab Versus Upfront Surgery for Patients With Primary Resectable and Borderline Resectable Perihilar and Distal Cholangiocarcinoma
extrahepatic cholangiocarcinoma, perihilar cholangiocarcinoma, distal cholangiocarcinoma, resectable, borderline resectable, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 841720
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.